Assignee
VERSEAU THERAPEUTICS INC
US·1 granted patent·6 pending applications·0 citations·filing 2019–2021
Top patents by PatentIndex Score
7 records- 0144US2021317461A1Oligonucleotide compositions for targeting ccr2 and csf1r and uses thereofVERSEAU THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 0238US2023348603A1Anti-vsig4 compositions and methods for modulating myeloid cell inflammatory phenotypes and uses thereofVERSEAU THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0336US2022363752A1Anti-lrrc25 compositions and methods for modulating myeloid cell inflammatory phenotypes and uses thereofVERSEAU THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 0436US2022251233A1Anti-cd53 compositions and methods for modulating myeloid cell inflammatory phenotypes and uses thereofVERSEAU THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 0535US12552873B2Anti-PSGL-1 compositions and methods for modulating myeloid cell inflammatory phenotypes and uses thereofVERSEAU THERAPEUTICS INC·Filed 2020·Granted Feb 17, 2026·0 cites·29 claims
- 0634US2021189342A1Compositions and methods for modulating monocyte and macrophage inflammatory phenotypes and immunotherapy uses thereofVERSEAU THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 0734US2022396627A1Anti-siglec-9 compositions and methods for modulating myeloid cell inflammatory phenotypes and uses thereofVERSEAU THERAPEUTICS INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when VERSEAU THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →